Cardiac biomarkers and cardiovascular side effects are associated with a reduced mortality of oncological patients receiving BRAF/MEK-Inhibitor therapy
21 June 2025 (08:00 - 18:00)
Organised by: 
Abstract
About the speaker
Heidelberg (Germany)
59 More presentations in this session
Doctor M. Canavera Ibanez (Bogota, CO)
Doctor B. Andrade (Santarem, PT)
Doctor B. Aumente Rodriguez (Salamanca, ES)
Access the full session
The Event
ESC Cardio-Oncology 2025
21 June 2025
08:00 CET
You may be interested in
Congress Presentation
